home / stock / cycc / cycc short
Short Information | Cyclacel Pharmaceuticals Inc. (NASDAQ:CYCC)
Twenty Trading Day Totals | |
---|---|
Total Shorted Volume | 209,749 |
Total Actual Volume | 744,345 |
Short Trends | |
---|---|
Cover Days | 15 |
Short Days | 0 |
No Change Days | 5 |
Averages | |
---|---|
Average Short Volume | 10,487 |
Average Short Percentage | 25.07% |
Is there a CYCC Short Squeeze or Breakout about to happen?
See the CYCC Short Analysis for free Sign up or Login
Powered by Squeeze Report
Date | Open | Close | High | Low | Total Volume | Short Volume | Short Percentage |
---|---|---|---|---|---|---|---|
04-17-2024 | $1.67 | $1.96 | $2.0899 | $1.67 | 115,080 | 46,619 | 40.51% |
04-16-2024 | $1.52 | $1.67 | $1.72 | $1.52 | 48,891 | 20,512 | 41.95% |
04-15-2024 | $1.76 | $1.57 | $1.84 | $1.57 | 38,778 | 7,809 | 20.14% |
04-12-2024 | $1.91 | $1.76 | $1.91 | $1.76 | 29,512 | 9,930 | 33.65% |
04-11-2024 | $2 | $1.94 | $2.05 | $1.91 | 24,158 | 1,576 | 6.52% |
04-10-2024 | $2.09 | $2.05 | $2.11 | $1.95 | 38,282 | 15,268 | 39.88% |
04-09-2024 | $2.07 | $2.11 | $2.13 | $2.07 | 5,730 | 865 | 15.1% |
04-08-2024 | $2.05 | $2.11 | $2.1399 | $2.05 | 24,922 | 2,838 | 11.39% |
04-05-2024 | $2.21 | $2.1 | $2.21 | $2.03 | 17,941 | 529 | 2.95% |
04-04-2024 | $2.13 | $2.1927 | $2.1927 | $2.12 | 3,799 | 498 | 13.11% |
04-03-2024 | $2.1541 | $2.19 | $2.22 | $2.0712 | 21,579 | 4,460 | 20.67% |
04-02-2024 | $2 | $2.12 | $2.1491 | $2 | 20,139 | 8,511 | 42.26% |
04-01-2024 | $2.2 | $2.05 | $2.2311 | $2.0101 | 22,065 | 5,062 | 22.94% |
03-28-2024 | $1.99 | $2.1099 | $2.14 | $1.99 | 46,138 | 22,927 | 49.69% |
03-27-2024 | $2.09 | $1.96 | $2.09 | $1.94 | 14,688 | 4,356 | 29.66% |
03-26-2024 | $2.11 | $1.92 | $2.18 | $1.8201 | 107,917 | 20,475 | 18.97% |
03-25-2024 | $2.14 | $2.14 | $2.2199 | $2.058 | 58,529 | 14,845 | 25.36% |
03-22-2024 | $2.09 | $2.188 | $2.23 | $2.07 | 36,905 | 11,033 | 29.9% |
03-21-2024 | $2.27 | $2.18 | $2.2979 | $2.08 | 20,093 | 4,453 | 22.16% |
03-20-2024 | $2.31 | $2.2499 | $2.31 | $2.16 | 49,199 | 7,183 | 14.6% |
News, Short Squeeze, Breakout and More Instantly...
Cyclacel Pharmaceuticals Inc. Company Name:
CYCC Stock Symbol:
NASDAQ Market:
- New clinical, PK and PD data from novel CDK2/9 inhibitor fadraciclib monotherapy studies support ongoing development program in patients with solid tumors and lymphoma - BERKELEY HEIGHTS, N.J., April 01, 2024 (GLOBE NEWSWIRE) -- Cyclacel Pharmaceuticals, Inc. (NASDAQ: CYCC, NASDAQ: CYCCP;...
– On Track to Start Oral Fadraciclib Phase 2 Proof of Concept in 1H 2024 – – Expect to Report Final Data from Fadraciclib 065-101 Dose Escalation – – Oral Plogosertib Preclinical Data Support Precision Med...
Caleres Inc. (CAL) is expected to report $0.86 for Q4 2024 B Communications Ltd (BCOMF) is expected to report for quarter end 2023-12-31 Dermata Therapeutics Inc. (DRMA) is expected to report for Q4 2023 Core & Main Inc. Class A (CNM) is expected to report $0.34 for Q4 2024 Wi...